330 related articles for article (PubMed ID: 6172216)
1. Predictive value of urinary N-acetyl-beta-D-glucosaminidase (NAG), alanine-aminopeptidase (AAP) and beta-2-microglobulin (beta 2M) in evaluating nephrotoxicity of gentamicin.
Gibey R; Dupond JL; Alber D; Leconte des Floris R; Henry JC
Clin Chim Acta; 1981 Oct; 116(1):25-34. PubMed ID: 6172216
[TBL] [Abstract][Full Text] [Related]
2. Chronic renal tubular effects in relation to urine cadmium levels.
Mueller PW; Smith SJ; Steinberg KK; Thun MJ
Nephron; 1989; 52(1):45-54. PubMed ID: 2565539
[TBL] [Abstract][Full Text] [Related]
3. N-acetyl-beta-glucosaminidase and beta 2-microglobulin. Their urinary excretion in patients with renal parenchymal disease.
Sherman RL; Drayer DE; Leyland-Jones BR; Reidenberg MM
Arch Intern Med; 1983 Jun; 143(6):1183-5. PubMed ID: 6190447
[TBL] [Abstract][Full Text] [Related]
4. Urinary N-acetyl-beta-D-glucosaminidase and beta 2-microglobulin in 'itai-itai' disease.
Nogawa K; Yamada Y; Honda R; Tsuritani I; Ishizaki M; Sakamoto M
Toxicol Lett; 1983 May; 16(3-4):317-22. PubMed ID: 6190270
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of urinary N-acetyl-beta-D-glucosaminidase and alanine aminopeptidase.
Hsu WS; Kao JT; Chen JS
Taiwan Yi Xue Hui Za Zhi; 1989 Apr; 88(4):407-9. PubMed ID: 2571671
[TBL] [Abstract][Full Text] [Related]
6. The relationship between enzymuria and kidney enzyme activities in experimental gentamicin nephrotoxicity.
Whiting PH; Brown PA
Ren Fail; 1996 Nov; 18(6):899-909. PubMed ID: 8948524
[TBL] [Abstract][Full Text] [Related]
7. [Urinary excretion of glycine.prolile dipeptidile aminopeptidase, N-acetyl-beta-D-glucosaminidase, alanine aminopeptidase and low molecular protein in patients with renal cell carcinoma].
Kitamura Y; Watanabe M; Komatsubara S; Sakata Y
Hinyokika Kiyo; 1990 May; 36(5):535-9. PubMed ID: 1698011
[TBL] [Abstract][Full Text] [Related]
8. Urinary excretion of N-acetyl-glucosaminidase and beta-2-microglobulin as early markers of gentamicin nephrotoxicity in neonates.
Gouyon JB; Aujard Y; Abisror A; Laudignon N; d'Athis P; Jacqz E; Biou D; Demelier JF; Mathieu H
Dev Pharmacol Ther; 1987; 10(2):145-52. PubMed ID: 3301233
[TBL] [Abstract][Full Text] [Related]
9. Urinary alanine aminopeptidase and beta 2-microglobulin as measurements of aminoglycoside-associated renal impairment.
Trollfors B; Bergmark J; Hiesche K; Jagenburg R
Infection; 1984; 12(1):20-2. PubMed ID: 6142864
[TBL] [Abstract][Full Text] [Related]
10. Significance of the measurement of urinary alanine aminopeptidase and N-acetyl-beta-D-glucosaminidase activity in evaluating patients with essential hypertension.
Kohno M; Kanayama Y; Yasunari K; Kawarabayashi T; Murakawa K; Takeuchi K; Inoue T; Takeda T
Clin Exp Hypertens A; 1985; 7(10):1347-60. PubMed ID: 2866856
[TBL] [Abstract][Full Text] [Related]
11. Urinary excretion of N-acetyl-beta-D-glucosaminidase and alanine aminopeptidase during pregnancy.
Strigini F; Melis GB; Gasperini M; Ronca G; Palmieri L; Fioretti P
Int J Gynaecol Obstet; 1989 Jan; 28(1):9-12. PubMed ID: 2565837
[TBL] [Abstract][Full Text] [Related]
12. Assessment of renal function during high-dose cis-platinum therapy in patients with ovarian carcinoma.
Buamah PK; Howell A; Whitby H; Harpur ES; Gescher A
Cancer Chemother Pharmacol; 1982; 8(3):281-4. PubMed ID: 6127169
[TBL] [Abstract][Full Text] [Related]
13. [Urinary excretion of N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzyme B as a marker of the nephrotoxicity of gentamicin: re-test from an animal model].
Ali-Miraftab H; Bourbouze R; Bondiou MT; Percheron F
Pathol Biol (Paris); 1988 Mar; 36(3):240-4. PubMed ID: 3283687
[TBL] [Abstract][Full Text] [Related]
14. Chrononephrotoxicity in rat of a vancomycin and gentamicin combination.
Fauconneau B; De Lemos E; Pariat C; Bouquet S; Courtois P; Piriou A
Pharmacol Toxicol; 1992 Jul; 71(1):31-6. PubMed ID: 1355906
[TBL] [Abstract][Full Text] [Related]
15. Enzyme activities of urinary alanine aminopeptidase (AAP) and N-acetyl-beta-D-glucosaminidase (NAG) in healthy dogs.
Reusch C; Vochezer R; Weschta E
Zentralbl Veterinarmed A; 1991 Mar; 38(2):90-8. PubMed ID: 1677227
[TBL] [Abstract][Full Text] [Related]
16. Alanine aminopeptidase and beta 2-microglobulin excretion in patients receiving vancomycin and gentamicin.
Rybak MJ; Frankowski JJ; Edwards DJ; Albrecht LM
Antimicrob Agents Chemother; 1987 Oct; 31(10):1461-4. PubMed ID: 2893584
[TBL] [Abstract][Full Text] [Related]
17. Age related changes of N-acetyl-beta-D-glucosaminidase and L-alanine aminopeptidase in mouse kidney, urine and plasma.
Funakawa S; Itoh T; Nakamura M; Tochino Y
Life Sci; 1987 Mar; 40(12):1193-9. PubMed ID: 2882396
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of urinary alanine aminopeptidase and N-acetyl-beta-D-glucosaminidase in comparison to alpha 1-microglobulin as a marker in evaluating tubular dysfunction in glomerulonephritis patients.
Holdt-Lehmann B; Lehmann A; Korten G; Nagel H; Nizze H; Schuff-Werner P
Clin Chim Acta; 2000 Jul; 297(1-2):93-102. PubMed ID: 10841912
[TBL] [Abstract][Full Text] [Related]
19. [Enzymuria and kidney diseases in childhood].
Ehrich JH; Wurster U; Lütge M; Doehring E; Oemar B
Monatsschr Kinderheilkd; 1986 Dec; 134(12):832-9. PubMed ID: 2881198
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic effects and influence on the urinary enzyme activity of human urinary trypsin inhibitor (urinastatin) in cases with acute renal failure--changes in the urinary activities of NAG and AAP].
Soejima A; Suzuki M; Kamiya K; Motohasi S; Nakabayashi K; Kitamoto K; Nagasawa T
Nihon Jinzo Gakkai Shi; 1989 Sep; 31(9):985-90. PubMed ID: 2573748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
